Becton Dickinson (BDX) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Becton Dickinson (BDX) do?
Becton Dickinson & Co (BDX) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures medical devices, laboratory equipment, and diagnostic products used in healthcare settings. It produces massive volumes of essential medical consumables like syringes, needles, and diagnostic tubes used globally. It is worth $57.93B on the market and sold $20.26B over the last year.
- Market cap
- $57.93B
- P/E ratio
- 51.4×
- Annual sales
- $20.26B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 13, 2026
Brands and businesses behind BDX
- BD Vacutainer: Manufactures blood collection tubes and needles, generating revenue through recurring consumable sales to clinical laboratories worldwide.
- BD Pyxis: Sells automated medication and supply management systems to hospitals through equipment sales and recurring maintenance contracts.
- BD Alaris: Provides hospital infusion pump systems and generates money from hardware sales, dedicated disposable sets, and software upgrades.
- PureWick: Offers noninvasive urine collection systems, earning revenue through ongoing direct-to-consumer and hospital supply sales.
- BD FACSCanto: Builds clinical flow cytometry systems, earning revenue from device installations, calibration services, and specialized reagent kits.
BDX’s flags, in plain English
Each flag is a number from Becton Dickinson’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.
Wide Gross Margin
Gross margin of 56% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Pays You to Hold
Pays a 1.93% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.
Runway Is Short
This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about BDX
How big is Becton Dickinson?
Becton Dickinson’s market cap is $57.93B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $20.26B: what customers paid the company over the last year, before any costs.
What is BDX’s P/E ratio?
BDX’s P/E ratio is 51.4×. Investors pay about 51.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with BDX?
The company carries over fifteen billion dollars in long-term debt following major historical acquisitions. That is one risk on Becton Dickinson’s card. Its first risk flag is Runway Is Short, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Becton Dickinson’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BDX’s filings on SEC.gov. The Margin Monkey is research, not advice.
